522 Results

People

  1. De Angelis
    De Angelis
  2. Kris
    Kris
  3. Motzer
    Motzer
  4. Livingston
    Livingston
  5. Aghajanian
    Aghajanian
  6. Krown
    Krown
  7. Panageas
    Panageas
  8. Miller
    Miller
  9. Tyson
    Tyson
  10. Vickers
    Vickers

Groups

  1. Department of Medicine (289)
  2. Solid Tumor Oncology Division (180)
  3. Hematologic Malignancies, Division of (104)
  4. Center for Hematologic Malignancies (92)
  5. Survivorship Research (61)
  6. GSK Faculty (55)
  7. Tow Center for Developmental Oncology (TCDO) (51)
  8. Epidemiology and Biostatistics (49)
  9. Population Sciences Research Program (45)
  10. Genitourinary Oncology Service (41)
  1. "headache"
Formats
  1. Journal Article (491)
  2. Review (17)
  3. Research Letter (5)
  4. Conference Paper (3)
  5. Editorial (3)
  6. Book Whole (1)
  7. Guidelines (1)
  8. Miscellaneous (1)
Groups
  1. Department of Medicine (289)
  2. Solid Tumor Oncology Division (180)
  3. Hematologic Malignancies, Division of (104)
  4. Center for Hematologic Malignancies (92)
  5. Survivorship Research (61)
  6. GSK Faculty (55)

More Groups

People
  1. Lisa De Angelis (20)
  2. Mark Kris (20)
  3. Robert Motzer (19)
  4. Philip Livingston (13)
  5. Carol Aghajanian (12)
  6. Katherine Panageas (12)

More People

Years
  1. 2025 (15)
  2. 2024 (34)
  3. 2023 (30)
  4. 2022 (16)
  5. 2021 (18)
  6. 2020 (35)

More Years

Publications
  1. Journal of Clinical Oncology (37)
  2. Clinical Cancer Research (23)
  3. Lancet Oncology (20)
  4. Blood (18)
  5. New England Journal of Medicine (17)
  6. Cancer (16)

More Publications

Publishers
  1. Elsevier Inc. (68)
  2. Elsevier Science, Inc. (43)
  3. Springer (42)
  4. American Society of Clinical Oncology (37)
  5. Nature Publishing Group (32)
  6. Oxford University Press (29)

More Publishers

Results (522)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Treatment discontinuation, patient-reported toxicities and quality-of-life by age following trastuzumab emtansine or paclitaxel/trastuzumab (ATEMPT)
    Journal Article

    Sella, T.; Zheng, Y.; Tayob, N.; Ruddy, K. J.; Freedman, R. A.; Dang, C.; Yardley, D.; Isakoff, S. J.; Valero, V.; DeMeo, M.; more...
    npj Breast Cancer (2022)

    Fulltext@MSK | Save
  • Eprenetapopt plus azacitidine after allogeneic hematopoietic stem-cell transplantation for TP53 -mutant acute myeloid leukemia and myelodysplastic syndromes
    Journal Article

    Mishra, A.; Tamari, R.; DeZern, A. E.; Byrne, M. T.; Gooptu, M.; Chen, Y. B.; Deeg, H. J.; Sallman, D.; Gallacher, P.; Wennborg, A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Ibrutinib treatment of pediatric chronic graft-versus-host disease: Primary results from the phase 1/2 iMAGINE study
    Journal Article

    Carpenter, P. A.; Kang, H. J.; Yoo, K. H.; Zecca, M.; Cho, B.; Lucchini, G.; Nemecek, E. R.; Schultz, K. R.; Stepensky, P.; Chaudhury, S.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Nivolumab plus ipilimumab plus cabozantinib triplet combination for patients with previously untreated advanced renal cell carcinoma: Results from a discontinued arm of the phase III CheckMate 9ER trial
    Journal Article

    Apolo, A. B.; Powles, T.; Escudier, B.; Burotto, M.; Zhang, J.; Simsek, B.; Scheffold, C.; Motzer, R. J.; Choueiri, T. K.
    European Journal of Cancer (2022)

    Fulltext@MSK | Save
  • Lenvatinib plus pembrolizumab in Japanese patients with endometrial cancer: Results from Study 309/KEYNOTE-775
    Journal Article

    Yonemori, K.; Yunokawa, M.; Ushijima, K.; Sakata, J.; Shikama, A.; Minobe, S.; Usami, T.; Enomoto, T.; Takehara, K.; Hasegawa, K.; more...
    Cancer Science (2022)

    Fulltext@MSK | Save
  • A randomised phase II trial of a trivalent ganglioside vaccine targeting GM2, GD2 and GD3 combined with immunological adjuvant OPT-821 versus OPT-821 alone in metastatic sarcoma patients rendered disease-free by surgery
    Journal Article

    Rosenbaum, E.; Chugh, R.; Ryan, C. W.; Agulnik, M.; Milhem, M. M.; George, S.; Jones, R. L.; Chmielowski, B.; Van Tine, B. A.; Tawbi, H.; more...
    European Journal of Cancer (2022)

    Fulltext@MSK | Save
  • Olaparib treatment for platinum-sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency status: Phase II LIGHT study primary analysis
    Journal Article

    Cadoo, K.; Simpkins, F.; Mathews, C.; Liu, Y. L.; Provencher, D.; McCormick, C.; ElNaggar, A. C.; Altman, A. D.; Gilbert, L.; Black, D.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Phase Ib study of eprenetapopt (APR-246) in combination with pembrolizumab in patients with advanced or metastatic solid tumors
    Journal Article

    Park, H.; Shapiro, G. I.; Gao, X.; Mahipal, A.; Starr, J.; Furqan, M.; Singh, P.; Ahrorov, A.; Gandhi, L.; Ghosh, A.; more...
    ESMO Open (2022)

    Fulltext@MSK | Save
  • Craniopharyngiomas invading the ventricular system: A systematic review
    Review

    Palmisciano, P.; Young, K.; Ogasawara, M.; Yousefi, O.; Ogasawara, C.; Ferini, G.; Bin-Alamer, O.; Sharma, M.; Umana, G. E.; Yu, K.; more...
    Anticancer Research (2022)

    Fulltext@MSK | Save
  • Predictors of chronic COVID-19 symptoms in a community-based cohort of adults
    Journal Article

    Silverberg, J. I.; Zyskind, I.; Naiditch, H.; Zimmerman, J.; Glatt, A. E.; Pinter, A.; Theel, E. S.; Joyner, M. J.; Hill, D. A.; Lieberman, M. R.; more...
    PLoS ONE (2022)

    Fulltext@MSK | Save